We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PFX:NASDAQPhenixFIN Corporation Analysis

Data as of 2026-04-24 - not real-time

$39.81

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: The stock is trading below its short‑term and intermediate moving averages, with the 20‑day SMA under the 50‑day and 200‑day levels, signaling a bearish momentum. The MACD histogram is negative and the signal line is bearish, while the RSI sits in a neutral zone, offering little upside momentum. Volume has been trending down, and the 30‑day volatility is elevated, suggesting price swings may continue.
Fundamental backdrop: The company reports a negative profit margin and operating cash flow deficits, coupled with a very high debt‑to‑equity ratio, which raises concerns about financial stability. However, the price‑to‑book ratio is well below one, indicating the market is pricing the equity at a discount to its book value. The forward earnings estimate is positive, but current earnings are negative, and there is no dividend history. Recent news highlights that the stock slipped below a key trend level, drawing attention from insiders and institutional investors, which could add short‑term pressure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical indicators (price below key moving averages, negative MACD)
  • Decreasing volume and high short‑term volatility
  • Negative earnings and cash flow pressure

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential price appreciation if market re‑prices book value
  • Forward earnings outlook turning positive
  • Continued financial strain from high leverage

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant discount to book value offering upside potential
  • Asset‑backed portfolio may generate stable returns over time
  • Improved earnings trajectory expected as investments mature

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin-11.98%
P/E Ratio18.8
ROE-1.93%
ROA3.19%
Debt/Equity95.64
P/B Ratio0.5
Op. Cash Flow$-3097083
Free Cash Flow$-1014604
Industry P/E17.3

Technical Analysis

TrendBearish
RSI42.3
Support$38.30
Resistance$42.54
MA 20$40.42
MA 50$41.64
MA 200$44.86
MACDBearish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.13
Volatility29.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.